Corrigendum to "Suppression of experimental autoimmune myasthenia gravis by combination therapy: Pentoxifylline as a steroid-sparing agent" [J. Neuroimmunol. 201-202 (2008) 128-135] (DOI:10.1016/j.jneuroim.2008.05.023)

TY - JOUR

T1 - Corrigendum to "Suppression of experimental autoimmune myasthenia gravis by combination therapy

T2 - Pentoxifylline as a steroid-sparing agent" [J. Neuroimmunol. 201-202 (2008) 128-135] (DOI:10.1016/j.jneuroim.2008.05.023)

AU - Menon, Renuka T.R.

AU - Feferman, Tali

AU - Aricha, Revital

AU - Souroujon, Miriam C.

AU - Fuchs, Sara

N1 - Funding Information: This research was supported by grants from The Muscular Dystrophy Association of America (MDA), The Association Francaise Cortre les Myopathies (AFM), The European Commission (EC, No QLG1-CT-2001-10918, QLRT-2001-00225 and LSHN-CT-2006-037833) and The Chief Scientist Office, Israel Ministry of Health.

PY - 2009/10/30

Y1 - 2009/10/30

UR - http://www.scopus.com/inward/record.url?scp=70349740876&partnerID=8YFLogxK

U2 - 10.1016/j.jneuroim.2009.07.001

DO - 10.1016/j.jneuroim.2009.07.001

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.comment???

AN - SCOPUS:70349740876

SN - 0165-5728

VL - 215

SP - 129

JO - Journal of Neuroimmunology

JF - Journal of Neuroimmunology

IS - 1-2

ER -